Context Therapeutics Inc. Files 2025 Proxy Statement
Ticker: CNTX · Form: DEF 14A · Filed: Apr 15, 2025 · CIK: 1842952
| Field | Detail |
|---|---|
| Company | Context Therapeutics Inc. (CNTX) |
| Form Type | DEF 14A |
| Filed Date | Apr 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, corporate-governance, executive-compensation
Related Tickers: CTX
TL;DR
CTXCTX proxy filed - vote on board & pay for 2024. Meeting June 12.
AI Summary
Context Therapeutics Inc. filed its definitive proxy statement on April 15, 2025, for its annual meeting on June 12, 2025. The filing details executive compensation, board nominations, and other corporate governance matters for the fiscal year ending December 31, 2024. Key individuals mentioned include Martin Lehr, Alex Levit, Jennifer Minai Azary, and Claudio Dansky Ullman, MD, who are members of the board or involved in governance.
Why It Matters
This filing provides shareholders with crucial information regarding the company's leadership, compensation, and voting matters, enabling informed participation in corporate decisions.
Risk Assessment
Risk Level: low — This is a routine annual proxy filing and does not contain new material financial or operational information that would typically indicate high risk.
Key Numbers
- 20250612 — Annual Meeting Date (Shareholders will vote on proposals at this date.)
- 2024-12-31 — Fiscal Year End (The compensation and performance details in the filing relate to this period.)
Key Players & Entities
- Context Therapeutics Inc. (company) — Registrant
- Martin Lehr (person) — Board Member
- Alex Levit (person) — Board Member
- Jennifer Minai Azary (person) — Board Member
- Claudio Dansky Ullman, MD (person) — Board Member
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose is to provide shareholders with information for the annual meeting, including details on executive compensation, board nominations, and other corporate governance matters.
When is the annual meeting of Context Therapeutics Inc. scheduled?
The annual meeting is scheduled for June 12, 2025.
Who are some of the key individuals mentioned in relation to the board or governance?
Key individuals mentioned include Martin Lehr, Alex Levit, Jennifer Minai Azary, and Claudio Dansky Ullman, MD.
What is the fiscal year end for Context Therapeutics Inc. that this filing pertains to?
The filing pertains to the fiscal year ending December 31, 2024.
What is the company's business address?
The company's business address is 2001 Market Street, Suite 3915, Unit #15, Philadelphia, PA 19103.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 15, 2025 by Martin Lehr regarding Context Therapeutics Inc. (CNTX).